Effect of dipeptidyl peptidase-4 inhibitors on complement activation.
Hoffmann-Petersen IT, Holt CB, Jensen L, Hage C, Mellbin LG, Thiel S, Hansen TK, Østergaard JA.
Hoffmann-Petersen IT, et al. Among authors: jensen l.
Diabetes Metab Res Rev. 2021 Mar;37(3):e3385. doi: 10.1002/dmrr.3385. Epub 2020 Aug 18.
Diabetes Metab Res Rev. 2021.
PMID: 32662092
Clinical Trial.